Back to search

Article

APP Dosage and Extracellular Domain Variants Drive Distinct Defects in Neurogenesis modeled in Down Syndrome iPS cells

2026-08-06

Abstract excerpt

<h4>ABSTRACT</h4> The amyloid precursor protein (APP) is heavily studied as the source of amyloid beta in Alzheimer’s disease (AD), however, the complex functions of APP remain poorly understood, as does the impact of APP dosage on neurodevelopment. Here we study APP specifically in the context of Trisomy 21. In an effort to reduce APP dosage in trisomy 21 iPSCs, we generated trisomic isogenic lines which vary in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
54d21b29-db75-5aa8-9d8d-9dad2cb25e65
DOI
10.64898/2026.08.05.742240
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
APP Dosage and Extracellular Domain Variants Drive Distinct Defects in Neurogenesis modeled in Down Syndrome iPS cellsDOI 10.64898/2026.08.05.742240
Select a neighboring publication to make it the new centre.